Adult-Onset IgA Vasculitis Complicated by Kidney Failure at Disease Onset in a Nepalese Patient: A Case Report


Authors : Omkar Jha; Shushant Guragain; Bishow Raj Gyawali; Ajit Kumar Sah; Isha Paudel; Sneha Shah

Volume/Issue : Volume 9 - 2024, Issue 9 - September

Google Scholar : https://tinyurl.com/4mtpc3rf

Scribd : https://tinyurl.com/5746vzvz

DOI : https://doi.org/10.38124/ijisrt/IJISRT24SEP691

PlumX Metrics

Semantic Scholar

ResearchGate

Note : A published paper may take 4-5 working days from the publication date to appear in PlumX Metrics, Semantic Scholar, and ResearchGate.

Abstract : Introduction: Immunoglobulin A (IgA) vasculitis, previously known as Henoch-Schönlein purpura, is an immune complex-mediated small vessel vasculitis primarily affecting children. While rare in adults, it can present with more severe manifestations, particularly involving the kidneys. This case report details the presentation and management of adult-onset IgA vasculitis with significant renal involvement.  Case Report: A 43-year-old male with a history of bipolar disorder presented with facial swelling, shortness of breath, and decreased urine output following an upper respiratory infection. Initial investigations revealed elevated blood pressure and renal impairment. Despite supportive treatment, his condition worsened, leading to a referral to a tertiary care center. He exhibited symptoms consistent with IgA vasculitis, including joint pain, rash, and nephrotic-range proteinuria. The diagnosis was confirmed through a skin biopsy and 24-hour urine collection. The patient was treated with intravenous methylprednisolone, oral prednisone, and an ACE inhibitor. His renal function improved with this regimen.  Discussion: Adult-onset IgA vasculitis can present with severe kidney involvement, including nephrotic-range proteinuria and elevated serum creatinine, which are associated with poorer outcomes compared to pediatric cases. The patient's management, involving glucocorticoids and an ACE inhibitor, aligns with current treatment recommendations for significant renal involvement. Long-term prognosis in adults remains challenging, with a higher risk of end-stage kidney disease compared to children. Vigilant monitoring and tailored treatment strategies are crucial for improving outcomes.  Conclusion: This case underscores the potential severity of adult- onset IgA vasculitis and highlights the importance of early diagnosis and aggressive management to mitigate long- term renal complications. Ongoing research is necessary to refine treatment approaches and enhance outcomes for adults with this condition.

Keywords : IgA Vasculitis, Henoch-Schönlein Purpura, Proteinuria, Prednisolone, ACE- Inhibitor, Vasculitis.

References :

  1. Audemard-Verger A, Pillebout E, Guillevin L, Thervet E, Terrier B: IgA vasculitis (Henoch-Shönlein purpura) in adults: Diagnostic and therapeutic aspects. Autoimmunity reviews. 2015, 14:579-585. 10.1016/j.autrev.2015.02.003
  2. Byun JW, Song HJ, Kim L, Shin JH, Choi GS: Predictive relapse factors in adults with Henoch-Schönlein purpura. Am J Dermatopathol. 2012, 34:139-144. 10.1097/DAD.0b013e3182157f90
  3. Oni L, Sampath S: Childhood IgA Vasculitis (Henoch Schonlein Purpura)-Advances and Knowledge Gaps. Frontiers in pediatrics. 2019, 7:257. 10.3389/fped.2019.00257
  4. Blanco R, Martínez-Taboada VM, Rodríguez-Valverde V, García-Fuentes M, González-Gay MA: Henoch-Schönlein purpura in adulthood and childhood: two different expressions of the same syndrome. Arthritis and rheumatism. 1997, 40:859-864. 10.1002/art.1780400513
  5. Batu ED, Sarı A, Erden A, et al.: Comparing immunoglobulin A vasculitis (Henoch-Schönlein purpura) in children and adults: a single-center study from Turkey. Scandinavian journal of rheumatology. 2018, 47:481-486. 10.1080/03009742.2018.1448111
  6. Kang Y, Park JS, Ha YJ, et al.: Differences in clinical manifestations and outcomes between adult and child patients with Henoch-Schönlein purpura. Journal of Korean Medical Science. 2014, 29:198-203. 10.3346/jkms.2014.29.2.198
  7. Hočevar A, Rotar Z, Ostrovršnik J, et al.: Incidence of IgA vasculitis in the adult Slovenian population. The British journal of dermatology. 2014, 171:524-527. 10.1111/bjd.12946
  8. Pillebout E, Thervet E, Hill G, Alberti C, Vanhille P, Nochy D: Henoch-Schönlein Purpura in adults: outcome and prognostic factors. Journal of the American Society of Nephrology: JASN. 2002, 13:1271-1278. 10.1097/01.asn.0000013883.99976.22
  9. McCarthy HJ, Tizard EJ: Clinical practice: Diagnosis and management of Henoch-Schönlein purpura. European journal of pediatrics. 2010, 169:643-650. 10.1007/s00431-009-1101-2
  10. Kiryluk K, Moldoveanu Z, Sanders JT, et al.: Aberrant glycosylation of IgA1 is inherited in pediatric IgA nephropathy and Henoch-Schönlein purpura nephritis. Kidney international. 2011, 80:79-87. 10.1038/ ki.2011.16
  11. Chang WL, Yang YH, Wang LC, Lin YT, Chiang BL: Renal manifestations in Henoch-Schönlein purpura: a 10-year clinical study. Pediatric nephrology (Berlin, Germany). 2005, 20:1269-1272. 10.1007/s00467-005-1903-z
  12. Narchi H: Risk of long-term renal impairment and duration of follow-up recommended for Henoch-Schonlein purpura with normal or minimal urinary findings: a systematic review. Archives of disease in childhood. 2005, 90:916-920. 10.1136/adc.2005. 074641
  13. KDIGO 2021 Clinical Practice Guideline for the Management of Glomerular Diseases. Kidney international. 2021, 100:S1-s276. 10.1016/j.kint. 2021.05.021
  14. Ozen S, Marks SD, Brogan P, et al.: European consensus-based recommendations for diagnosis and treatment of immunoglobulin A vasculitis-the SHARE initiative. Rheumatology (Oxford, England). 2019, 58:1607-1616. 10.1093/rheumatology/kez041
  15. Hackl A, Becker JU, Körner LM, et al.: Mycophenolate mofetil following glucocorticoid treatment in Henoch-Schönlein purpura nephritis: the role of early initiation and therapeutic drug monitoring. Pediatric nephrology (Berlin, Germany). 2018, 33:619-629. 10.1007/s00467-017-3846-6
  16. Maritati F, Fenoglio R, Pillebout E, et al.: Brief Report: Rituximab for the Treatment of Adult-Onset IgA Vasculitis (Henoch-Schönlein). Arthritis & rheumatology (Hoboken, NJ). 2018, 70:109-114. 10.1002/art.40339
  17. Shi D, Chan H, Yang X, et al.: A meta-analysis: Risk factors associated with IgA vasculitis with nephritis (Henoch-Schönlein purpura nephritis) progressing to unfavorable outcomes. PloS one. 2019, 14:e0223218. 10.1371/journal.pone.0223218
  18. Coppo R, Andrulli S, Amore A, et al.: Predictors of outcome in Henoch-Schönlein nephritis in children and adults. American journal of kidney diseases: the official journal of the National Kidney Foundation. 2006, 47:993-1003. 10.1053/j.ajkd.2006.02.178
  19. Shrestha S, Sumingan N, Tan J, Alhous H, McWilliam L, Ballardie F: Henoch Schönlein purpura with nephritis in adults: adverse prognostic indicators in a UK population. QJM: monthly journal of the Association of Physicians. 2006, 99:253-265. 10.1093/qjmed/hcl034

Introduction: Immunoglobulin A (IgA) vasculitis, previously known as Henoch-Schönlein purpura, is an immune complex-mediated small vessel vasculitis primarily affecting children. While rare in adults, it can present with more severe manifestations, particularly involving the kidneys. This case report details the presentation and management of adult-onset IgA vasculitis with significant renal involvement.  Case Report: A 43-year-old male with a history of bipolar disorder presented with facial swelling, shortness of breath, and decreased urine output following an upper respiratory infection. Initial investigations revealed elevated blood pressure and renal impairment. Despite supportive treatment, his condition worsened, leading to a referral to a tertiary care center. He exhibited symptoms consistent with IgA vasculitis, including joint pain, rash, and nephrotic-range proteinuria. The diagnosis was confirmed through a skin biopsy and 24-hour urine collection. The patient was treated with intravenous methylprednisolone, oral prednisone, and an ACE inhibitor. His renal function improved with this regimen.  Discussion: Adult-onset IgA vasculitis can present with severe kidney involvement, including nephrotic-range proteinuria and elevated serum creatinine, which are associated with poorer outcomes compared to pediatric cases. The patient's management, involving glucocorticoids and an ACE inhibitor, aligns with current treatment recommendations for significant renal involvement. Long-term prognosis in adults remains challenging, with a higher risk of end-stage kidney disease compared to children. Vigilant monitoring and tailored treatment strategies are crucial for improving outcomes.  Conclusion: This case underscores the potential severity of adult- onset IgA vasculitis and highlights the importance of early diagnosis and aggressive management to mitigate long- term renal complications. Ongoing research is necessary to refine treatment approaches and enhance outcomes for adults with this condition.

Keywords : IgA Vasculitis, Henoch-Schönlein Purpura, Proteinuria, Prednisolone, ACE- Inhibitor, Vasculitis.

Video Explanation for Published paper

Never miss an update from Papermashup

Get notified about the latest tutorials and downloads.

Subscribe by Email

Get alerts directly into your inbox after each post and stay updated.
Subscribe
OR

Subscribe by RSS

Add our RSS to your feedreader to get regular updates from us.
Subscribe